oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound

NARecruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

September 4, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
Giant Cell Arteritis (GCA)
Interventions
DIAGNOSTIC_TEST

orbital ultrasound

orbital ultrasound at the beginning of the participation, and at 6 months after the inclusion.

Trial Locations (9)

Unknown

NOT_YET_RECRUITING

Rhumatology departement - Centre Hospitalier Aix en Provence, Aix-en-Provence

NOT_YET_RECRUITING

Rhumatology department - Centre Hospitalier Universitaire de Brest, Brest

RECRUITING

Internal Medecine Department- CHU Caen, Caen

NOT_YET_RECRUITING

Internal Medicine and Clinical Immulogy department - Centre Hospitalier Universitaire de Dijon, Dijon

NOT_YET_RECRUITING

Internal Medicine and VascularMedecine Department - Centre Hospitalier Universitaire de Nantes, Nantes

NOT_YET_RECRUITING

Internal Medicine department - Hôpital Saint-Antoine, Paris

NOT_YET_RECRUITING

Rhumatology department - Hôpital Bichat, Paris

NOT_YET_RECRUITING

Rhumatology department - Hôpital NOVO - Pontoise site, Pontoise

NOT_YET_RECRUITING

Rhumatology department - Centre Hospitalier Universitaire de Tours, Tours

All Listed Sponsors
lead

Hôpital NOVO

OTHER

NCT07001059 - oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound | Biotech Hunter | Biotech Hunter